Lesson
Define the Diarrhea Phenotype
Diarrhea is not one diagnosis. Duration, stool character, volume, timing, pain, exposures, and the response to fasting reveal whether the dominant process is infectious, osmotic, secretory, inflammatory, fatty, medication-related, or functional.
- Acute, persistent, and chronic duration
- Watery, fatty, and inflammatory stool
- Osmotic and secretory physiology
- Functional impact
- Baseline bowel pattern
Duration changes the likely causes and the need for testing.
Stool character reveals mechanism and urgency.
Burden matters alongside the number of stools.
Use duration as a diagnostic branch
Acute diarrhea lasts less than 14 days. Persistent diarrhea lasts 14 to 29 days. Chronic diarrhea lasts at least 4 weeks. A longer course increases the value of targeted testing and makes indefinite self-treatment inappropriate.
Characterize the stool
Watery stool can be osmotic or secretory. Greasy, floating, difficult-to-flush stool suggests fat malabsorption. Blood, mucus, fever, or severe pain raises concern for inflammatory or invasive disease.
Connect physiology to the history
Osmotic diarrhea often improves when a poorly absorbed solute is removed. Secretory diarrhea can continue during fasting. Inflammatory diarrhea reflects mucosal injury and may include blood, fever, urgency, and systemic illness.
Measure function, not count alone
The same stool frequency can be mild for one patient and incapacitating for another. Functional severity guides travelers' diarrhea treatment and clarifies whether the patient can hydrate, work, travel, or perform normal activity.
Quick check
Lesson
Triage Hydration and Alarm Features
The first decision is not which antidiarrheal to use. It is whether the patient can safely remain in outpatient self-care and whether the presentation permits symptom suppression.
- Volume status
- Dysentery
- Sepsis and severe pain
- High-risk hosts
- Escalation thresholds
Volume loss can be the immediate threat.
Dysentery moves care away from routine antimotility use.
Vulnerability lowers the threshold for escalation.
Recognize clinically important volume loss
Thirst, dry mucosa, tachycardia, orthostasis, reduced urine output, lethargy, confusion, cool extremities, and delayed capillary refill can signal dehydration. Hypotension, altered mentation, or poor perfusion requires urgent care.
Treat inflammatory features as a different pathway
Bloody stool, high fever, severe abdominal pain, peritoneal findings, toxic appearance, or sepsis can indicate invasive infection or another serious disease. Antimotility monotherapy is not appropriate in this setting.
Lower the threshold for vulnerable patients
Infants, older adults, pregnant patients, immunocompromised patients, and people with kidney, cardiovascular, or other major chronic disease can deteriorate faster and may require individualized fluids, testing, or treatment.
Name the stop rules
Persistent vomiting, inability to hydrate, worsening symptoms, blood, high fever, severe pain, abdominal swelling, reduced urine output, or symptoms that exceed the product label or expected course should end routine self-care.
Quick check
Lesson
Find the Cause Before Suppressing the Signal
A focused timeline often identifies the cause more efficiently than a large unselected test panel. Food, water, travel, contacts, medicines, supplements, healthcare exposure, and diet all belong in the initial history.
- Food and water exposures
- Travel and outbreaks
- Medication-induced diarrhea
- Lactose and poorly absorbed carbohydrates
- Healthcare exposure
Shared illness can identify transmission and public health risk.
New starts and dose changes can create a reversible cause.
Environment narrows the infectious differential.
Build an exposure map
Ask about untreated water, raw or undercooked food, unpasteurized products, sick contacts, childcare, animals, travel, recreational water, sexual exposure, and whether other people are ill. Shared illness can require public health action.
Audit the full medication list
Antibiotics, magnesium products, metformin, colchicine, laxatives, cholinesterase inhibitors, prokinetics, mycophenolate, protease inhibitors, and many other drugs can cause diarrhea. Include nonprescription products and supplements.
Use diet hypotheses carefully
Lactose, fructose, sorbitol, and other poorly absorbed carbohydrates can cause osmotic diarrhea. Use a focused, time-limited elimination and planned reassessment rather than broad permanent restriction without evidence.
Avoid prescribing cascades
When symptom onset follows a dose increase or new product, first ask whether the exposure can be reduced, replaced, or stopped safely. Chronic antidiarrheal therapy should not conceal an avoidable adverse effect.
Quick check
Lesson
Restore Water and Electrolytes
Oral rehydration is active transport therapy. A correctly balanced glucose and sodium solution uses intact intestinal cotransport to absorb sodium and water even while diarrhea continues.
- Sodium-glucose cotransport
- Reduced-osmolarity ORS
- Safe water and correct dilution
- Ongoing losses
- Continued feeding
Sodium and glucose enter the epithelial cell together.
A measured electrolyte solution replaces water without excess solute.
The correct water volume determines safety and performance.
Use the physiology
Glucose and sodium enter intestinal cells together through SGLT1, and water follows. WHO reduced-osmolarity oral rehydration solution contains 75 mmol/L sodium and 75 mmol/L glucose with a total osmolarity of 245 mOsm/L.
Mix packets exactly
Add the packet to the exact volume of safe water specified by the product, commonly one liter. Do not add extra sugar, salt, juice, or a second packet. Too little water creates an unsafe concentrated solution.
Choose fluids by severity
Preferred liquids can maintain hydration in mild illness. Moderate or substantial losses call for a balanced oral rehydration solution when oral intake is possible. Shock, severe dehydration, or failed oral intake requires urgent intravenous therapy.
Continue appropriate nutrition
Resume a tolerable regular diet once hydration is addressed. Continue breastfeeding and usual infant feeding when appropriate. Excessively sweet drinks can worsen osmotic diarrhea when consumed in quantity.
Quick check
Lesson
Select Diagnostic Tests That Change Care
Testing is valuable when the result can guide treatment, infection control, public health action, or a persistent-disease evaluation. Broad testing of every brief mild episode can detect colonization and create unnecessary treatment.
- Stool pathogen testing
- C. difficile
- Giardia
- Celiac disease
- Inflammatory and bile acid evaluation
Test when the result changes treatment or public health action.
Compatible symptoms and risk make the test interpretable.
Prioritize inflammation, Giardia, celiac disease, and bile acid diarrhea.
Test severe or epidemiologically important illness
Consider stool testing for blood or fever, severe abdominal pain, sepsis, prolonged disease, immunocompromise, outbreak risk, relevant travel, healthcare exposure, or a suspected pathogen with treatment or public health implications.
Test for C. difficile in the right patient
New unexplained unformed stool after antibiotics or healthcare exposure can justify C. difficile testing. Test symptomatic patients with an accepted algorithm. Testing formed stool or asymptomatic patients can misidentify colonization as disease.
Evaluate chronic watery diarrhea selectively
AGA guidance supports testing for Giardia and celiac disease, using fecal calprotectin or lactoferrin to screen for inflammatory disease, and considering bile acid diarrhea. Routine ova and parasite testing beyond Giardia is not recommended without relevant travel or exposure.
Do not diagnose IBS-D by exclusion alone
A positive symptom-based diagnosis can be appropriate after alarm features and selected treatable conditions are addressed. Chronic nocturnal symptoms, weight loss, anemia, blood, or changing physiology reopen the differential.
Quick check
Lesson
Build Supportive Care Around the Patient
Supportive care includes hydration, nutrition, skin protection, transmission control, medication review, and follow-up. It is not a placeholder while waiting for a drug.
- Nutrition
- Hand hygiene
- Food handling
- Skin protection
- Probiotic evidence
Replace losses and resume tolerable nourishment.
Reduce injury and interrupt fecal-oral spread.
Stop self-care when the phenotype or severity changes.
Protect nutrition and comfort
Resume tolerable foods and avoid only items that clearly worsen symptoms. Repeated stool can irritate perianal skin, so gentle cleansing and a barrier such as petrolatum or zinc oxide can reduce injury.
Interrupt transmission
Wash hands with soap and water after toileting and before food preparation. Food-service workers, healthcare workers, childcare staff, and people in outbreaks should follow local exclusion and reporting rules.
Use probiotics with precision
Probiotic evidence is strain-specific, product-specific, and indication-specific. CDC finds insufficient evidence to recommend probiotics for travelers' diarrhea prevention. Immunocompromised and critically ill patients require particular caution.
Use a defined follow-up window
Record stool burden, oral intake, urine output, fever, blood, pain, and response. A self-care plan should end when symptoms worsen, exceed label duration, or no longer fit the original low-risk phenotype.
Quick check
Lesson
Use Bismuth Subsalicylate Safely
Bismuth subsalicylate can reduce selected noninvasive diarrhea symptoms, but its salicylate component makes allergy, bleeding, age, pregnancy, kidney function, and drug interactions central to selection.
- Antisecretory effect
- Antimicrobial effect
- Concentration-aware dosing
- Salicylate risk
- Counseling
Selected noninvasive symptoms can improve.
Regular and maximum-strength liquids use different volumes.
Age, pregnancy, allergy, and interacting drugs shape selection.
Understand the role
Bismuth subsalicylate has antisecretory and antimicrobial activity. It can be considered for mild travelers' diarrhea or uncomplicated noninvasive diarrhea when hydration is protected and safety exclusions are absent.
Verify the concentration
Regular-strength liquid commonly provides 525 mg per 30 mL, while maximum-strength liquid can provide 525 mg per 15 mL. Tablet strengths also differ. Follow the exact Drug Facts label and do not transfer a volume from one concentration to another.
Screen salicylate risk
Avoid use with salicylate allergy, concurrent salicylates, selected anticoagulants, active bleeding risk, and viral illness in children or teenagers. CDC advises against use in pregnancy, gout, renal insufficiency, and with methotrexate or probenecid for travelers' diarrhea prevention.
Counsel on expected and toxic effects
Temporary darkening of the tongue or stool can occur and is usually harmless. Constipation, nausea, or tinnitus can signal intolerance or salicylate exposure. Persistent illness or use beyond two days requires evaluation.
Quick check
Lesson
Use Antimotility Therapy Within Boundaries
Loperamide and diphenoxylate reduce motility and stool frequency. They provide symptom relief, not cause control, and can be dangerous when the bowel should not be slowed or when doses exceed the label.
- Peripheral opioid action
- Loperamide dosing
- Inflammatory exclusions
- Cardiac toxicity
- Diphenoxylate and atropine
Inflammatory features exclude routine monotherapy.
Label boundaries protect against cardiac and gastrointestinal harm.
Toxicity and obstruction signals require urgent care.
Use loperamide for the right phenotype
Loperamide activates peripheral intestinal opioid receptors and slows transit. It can be considered for selected nonbloody, afebrile diarrhea. Do not use it to force symptomatic control when dysentery, invasive infection, acute colitis, abdominal swelling, or obstruction is suspected.
Respect dose and duration
Adult prescription labeling uses 4 mg initially, then 2 mg after each unformed stool, with a maximum of 16 mg daily. OTC products use a lower label maximum and direct patients to stop and seek care when symptoms last more than two days. Follow the exact product label.
Recognize cardiac toxicity
Higher-than-recommended doses can cause QT prolongation, torsades de pointes, ventricular arrhythmias, syncope, cardiac arrest, and death. Unexplained arrhythmia should prompt a specific loperamide exposure history and toxicology support.
Use diphenoxylate and atropine cautiously
Diphenoxylate is an opioid agonist and atropine adds anticholinergic effects. Current labeling indicates the tablets as adjunctive therapy for patients age 13 and older and contraindicates use below age 6 because of severe respiratory and central nervous system depression.
Quick check
Lesson
Match Travelers' Diarrhea Treatment to Severity
Travelers' diarrhea management begins with safe hydration and uses functional severity, invasive features, destination resistance, and stewardship to decide whether symptom therapy or a prescribed antibiotic plan is appropriate.
- Functional severity
- Oral rehydration
- Symptom therapy
- Antibiotic selection
- Resistance and stewardship
Hydration and selected symptom relief are usually enough.
A prescribed antibiotic plan can be considered.
Cause-directed treatment and evaluation take priority.
Use functional definitions
Mild illness is tolerable and does not interfere with activities. Moderate illness is distressing or interferes with activities. Severe illness is incapacitating, and all dysentery is severe.
Treat mild illness without antibiotics
For mild travelers' diarrhea, antibiotics are not recommended. Hydration plus selected bismuth or loperamide can be considered when safety screening permits.
Reserve antibiotics for defined need
Antibiotics can be used for moderate illness and are advised for severe illness. Azithromycin is preferred for dysentery, febrile diarrhea, and regions where fluoroquinolone resistance is suspected. Rifamycin SV and rifaximin are options only for noninvasive illness.
Account for antibiotic harm
Antibiotic treatment can shorten selected illness but can also cause adverse effects, C. difficile infection, and acquisition of resistant organisms. A standby regimen should be prescribed with explicit severity, duration, and escalation instructions.
Quick check
Lesson
Reassess Persistent and Chronic Diarrhea
When diarrhea persists, the task shifts from short symptom control to mechanism and cause. Protozoal infection, medication effects, celiac disease, inflammation, microscopic colitis, bile acid diarrhea, malabsorption, and endocrine or structural disease enter the pathway.
- Persistent post-travel diarrhea
- Giardia
- Bile acid diarrhea
- Malabsorption and inflammation
- Longitudinal reassessment
Duration after travel or water exposure changes probability.
Chronic watery or fatty patterns need targeted evaluation.
Nocturnal symptoms, weight loss, anemia, or blood reopen the case.
Treat duration as new evidence
Protozoa become more likely when post-travel diarrhea lasts more than two weeks. Giardia is a common treatable cause. Repeating empiric antimotility therapy is not a substitute for targeted testing.
Consider bile acid diarrhea
Excess bile acids reaching the colon can cause watery diarrhea, especially after ileal disease or resection. Testing availability varies, and any therapeutic trial should be clinician-guided, measured, and separated from drug-binding interactions.
Expand the differential rationally
Celiac disease, inflammatory bowel disease, microscopic colitis, pancreatic insufficiency, endocrine disease, colorectal disease, and medication injury require history-guided testing. Nocturnal diarrhea, weight loss, anemia, or blood argues against routine self-care.
Use current reproductive safety information
Pregnancy and lactation decisions require product-specific evidence, disease severity, maternal hydration, fetal or infant exposure, and alternatives. Do not use obsolete pregnancy-letter categories or assume that every antidiarrheal shares one risk profile.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 128 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.
- CDC Yellow Book 2026: Travelers' Diarrhea
- IDSA guideline for infectious diarrhea
- AGA guideline summary for chronic diarrhea evaluation
- WHO oral rehydration therapy and salts
- FDA loperamide cardiac safety communication
- DailyMed prescription loperamide labeling
- DailyMed OTC loperamide Drug Facts
- DailyMed bismuth subsalicylate Drug Facts
- DailyMed diphenoxylate and atropine labeling